A pay cut turned into a payday as the actor's decision to take theatrical rights instead of a fee reportedly paid off far beyond expectations, per Koimoi.
Ravi Teja's gamble on Irumudi has apparently paid off in a big way. According to Koimoi, the actor took home close to ₹47 crore from the film, and the number is striking given how modest his upfront fee actually was.
Here's the backstory. Coming off six flops in a row, Ravi Teja was reportedly in no position to demand his usual price tag. So he took a pay cut, charging just ₹8 crore upfront for Irumudi, per Koimoi's reporting. But instead of a standard profit-sharing arrangement on top of that, Mythri Movie Makers structured the deal differently. They handed him the theatrical rights for the Nizam region, meaning whatever the film earned there in theatres, minus commissions and expenses, would be his.
At the time, that looked like a modest consolation. Nobody expected Irumudi to do more than decent business in Nizam. Instead, the film blew past expectations there, and Ravi Teja has reportedly pocketed nearly ₹39 crore from that region alone once the deductions were made. Add the ₹8 crore fee to that, and you get the ₹47 crore figure being reported.
The bigger picture matters here too. Irumudi has crossed ₹192 crore net at the Indian box office, translating to roughly ₹227 crore gross, according to Koimoi's tracking. The film is winding down its theatrical run now and looks set to close somewhere between ₹194 and ₹196 crore net, just short of the ₹200 crore mark. Whatever the final tally, it's already the highest-grossing film of Ravi Teja's career, and by a wide margin over whatever came before it.
For an actor who'd gone quiet after a string of underperformers, that's about as clean a comeback as Tollywood offers. It also validates a deal structure that could easily have gone the other way. Had Irumudi limped through Nizam the way pre-release buzz suggested, Ravi Teja would have been sitting on a fee smaller than what he'd usually command, with nothing to show for the gamble.
Instead, producers now have a working template. Cut the upfront cost for an actor whose stock has dipped, hand them a slice of regional theatrical rights, and let the box office decide who wins. If Irumudi's numbers hold as the template, expect more studios to offer this kind of arrangement to actors looking to rebuild after a rough patch. Whether Ravi Teja himself sticks to conventional pay-or-profit deals for his next film, or pushes for similar rights-based terms again, is the more interesting question now that this one has worked out.
Be the first to comment
Join the argument. No password, just your email or a passkey.